Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Hanwha Aerospace signed a supply contract worth approximately KRW 473.1B with Korea Aerospace Industries (KAI) for 17 types of components for the initial mass production of the KF-21.
📊 [Key Disclosure Details & Summary of Figures]
- Company Name: Hanwha Aerospace Co., Ltd.
- Ticker Symbol: 012450
- Disclosure Type: Single Sales/Supply Contract
- Disclosure Date: 2024-11-25
- Contract Title: Supply Contract for 17 Types of Initial Mass Production Components for KF-21
- Contract Counterparty: Korea Aerospace Industries, Ltd. (KAI)
- Contract Amount: KRW 473.10B (KRW 473,098,793,200)
- Ratio to Recent Revenue: 5.06% (Based on 2023 consolidated revenue of KRW 9,359,005,981,309)
- Sales/Supply Region: Republic of Korea
- Contract Period: 2024-11-25 ~ 2028-06-30
- Contract Date: 2024-11-25
- Key Terms: Single supply contract for 17 types of aircraft components (Schedule and amounts subject to change during execution)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Monitoring Contract Execution and Revenue Recognition
This disclosure represents a long-term supply contract for 17 types of aircraft components related to the initial mass production of the KF-21 fighter aircraft. Tracking how progressive delivery revenue is reflected in consolidated financial statements over the contract period (November 25, 2024, to June 30, 2028) is essential for understanding the direct financial impact of this order on the company’s revenue and operating earnings. Detailed quarterly progress and changes in order backlog can be verified in the “Business Overview – Revenue and Order Status” section of upcoming Periodic Reports (Quarterly, Half-Yearly, or Annual Business Reports).
📢 Disclaimer and Source Notice
Source: This content was newly structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
